acute leukemia :
- n rapidly progressing leukemia
News & Articles
- ERYTECH Announces Fast Take-off of Its Phase IIb Study in Acute Myeloid Leukemia
LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH (NYSE Euronext Paris : FR0011471135 - ERYP) (Paris:ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces a fast take-off of its Phase IIb study in Acute Myeloid Leukemia (AML). The study, a multicentre, open, randomized, controlled ...
July 4, 2013 - Business Wire